Animal studies indicate that loss of PHEX function results in enhanced secretion of the phosphaturic hormone fibroblast growth factor 23 (FGF23), which leads to renal phosphate wasting, hypophosphatemia and insufficient calcitriol (1,25(OH)2D) synthesis [3, 4]. The gene discussed is FGF23; the disease is hypophosphatemia.